Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathy

Life Sciences

Volumn 82, Issue 15-16, 2008, Pages 823-830

  Dorajoo, Rajkumar S O ^a   Pereira, Barry P ^a   Yu, Zou ^a   Gopalakrishnakone, P ^a   Leong, Cheng Chee ^b   Wee, Aileen ^a   Lee, Edmund ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Multi drug resistance associated protein 1; Myopathy; Pathology; Statin

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; CYTOCHROME C OXIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MULTIDRUG RESISTANCE PROTEIN 1; PROBENECID; ROSUVASTATIN; SUCCINATE DEHYDROGENASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL VACUOLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYTOLYSIS; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG INDUCED DISEASE; MALE; MUSCLE MITOCHONDRION; MYOPATHY; NONHUMAN; PLANTARIS MUSCLE; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; TOXICITY TESTING;

ANIMALS; BODY WEIGHT; ELECTRON TRANSPORT COMPLEX IV; FLUOROBENZENES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA, MUSCLE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DISEASES; PARAFFIN EMBEDDING; PROBENECID; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RENAL AGENTS; SULFONAMIDES;

ANIMALIA; RATTUS;

EID: 41149099433     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.01.021     Document Type: Article

References (23)

1. Arora R., Leibo M., and Maldonado F. Statin-induced myopathy: the two faces of Janus. Journal of Cardiovascular Pharmacology and Therapeutics 11 2 (2006) 105-112
2. Bakos E., Evers R., Sinko E., Varadi A., Borst P., and Sarkadi B. Interaction of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Molecular Pharmacology 57 (2000) 760-768
3. Courtois A., Payen L., Lagadic D., Guillouzo, and Fardel O. Evidence for a multidrug resistance-associated protein 1 (MRP1) related transport system in cultured rat liver biliary epithelial cells. Life Sciences 64 9 (1999) 763-774
4. Dirks A.J., and Jones K.M. Statin-induced apoptosis and skeletal myopathy. American Journal of Physiology - Cell Physiology 291 (2006) C1208-C1212
5. Dupuy J., Lespine A., Sutra J.F., and Alvinerie M. The interaction between moxidectin and MDR transporters in primary cultures of rat hepatocytes. Journal of Veterinary Pharmacology and Therapeutics 29 (2006) 107-111
6. Hamilton K.O., Topp E., Makagiansar I., Siahaan T., Yazdanian, and Audus K.L. Multidrug resistance-associated protein 1 functional activity in calu-3 cells. Journal of Pharmacology and Experimental Therapeutics 298 (2001) 1199-1205
7. Hooijberg J.H., Brozterman H.J., Kool M., Assaraf Y.G., Peters G.J., Noordhius P., Scheper R.K., Borst P., Pinedo H.M., and Jansen G. Antifolate resistance mediated by the multidrug resistance protein MRP1 and MRP2. Cancer Research 59 (1999) 2532-2535
8. Jacobson T.A. Statin-safety: lessons from New Drug Application for marketed statins. American Journal of Cardiology 97 (2006) 44C-51C
9. Kuh H.J., and Shim C.K. Nonlinear renal excretion of theophyline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid in rats. Archives of Pharmacal Research 17 2 (1994) 124-130
10. Leslie E.M., Deeley R.G., and Cole S.P.C. Toxicological relevance of the multidrug resistance protein1, MRP1 (ABCC1) and related transporters. Toxicology 167 (2001) 3-23
11. Liao J.K., and Laufs U. Pleiotropic effects of statins. Annual Review of Pharmacology and Toxicology 45 (2005) 89-118
12. Littarru G.P., and Langsjoen P. Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion 7S (2007) S168-S174
13. Masereeuw R., van Pelt A.P., Willems H.G.M., and Russel G.M. Probenecid interferes with renal oxidative metabolism: a potential pitfall in its use as an inhibitor of drug transport. British Journal of Pharmacology 131 (2000) 57-62
14. Nagasawa K., Nagai K., Ishimoto A., and Fujimoto S. Transport mechanism for lovastatin acid in bovine kidney NBL-1 cells: kinetic evidences imply involvement of monocarboxylate transporter 4. International Journal of Pharmaceutics 262 1-2 (2003) 63-73
15. Paiva H., Thelen K.M., Van Coster R., Smet J., Matilla K.M., Laakso J., Lehtimaki T., Lutjohann D., and Laaksonen R. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clinical Pharmacology and Therapeutics 78 1 (2005) 60-68
16. Philips P.S., Haas R.H., Bannykh S., Hathaway S., Gray N.L., Kimura B.J., Vladutiu G.D., and England J.D.F. Statin-associated myopathy with normal creatinine kinase levels. Annals of Internal Medicine 137 (2002) 581-585
17. Schinkel A.H., and Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABD) family: an overview. Advanced Drug Delivery Reviews 55 (2003) 3-29
18. Seachrist J.L., Loi C., Evans M.G., Criswell K.A., and Rothwell C.E. Roles of exercise and pharmacokineticsin cerivastatin-induced skeletal muscle toxicity. Toxicological Sciences 88 2 (2005) 551-561
19. Shitara Y., and Sugiyama Y. Pharmacokinetics and pharmacodynamic alterations of 3-hydroxy-3-methylyglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacology and Therapeutics 112 1 (2006) 71-105
20. Takeda M., Noshiro R., Onozato M.L., Tojo A., Hasannejad H., Huang X.L., Narikawa S., and Emdou H. Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors. European Journal of Pharmacology 483 (2004) 133-138
21. Thompson P.D., Clarkson P., and Karas R.H. Statin-associated myopathy. Journal of the American Medical Association 289 13 (2003) 1681-1690
22. Tirona R.G. Ethnic differences in statin disposition. Clinical Pharmacology and. Therapeutics 78 4 (2005) 311-315
23. Westwood F.R., Bigley A., Randall K., Marsden A.M., and Scott R.C. Statin-induced muscle necrosisin the rat: distribution, development and fiber sensitivity. Toxicologic Pathology 33 (2005) 246-257